Ye and colleagues demonstrated an association between a decreased CMG2 mRNA expression and a higher tumor stage in breast cancer; additionally, decreased CMG2 mRNA levels were significantly associated with a worsened disease-specific and overall survival [35]. Here, ANTXR2 is linked to breast cancer.